ANN BUNKER: Open Payments
NPI 1861878753 · LOWER GWYNEDD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 32 payments from 14 companies in 2025. Trend: 2023 $216 · 2024 $500 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $149 |
| AstraZeneca Pharmaceuticals LP | 4 | $146 |
| Amgen Inc. | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $119 |
| Lilly USA, LLC | 4 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| COLOPLAST CORP | 1 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| OPKO Pharmaceuticals, LLC | 2 | $40 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
Products named: IBSRELA, TAVNEOS, JARDIANCE, BREZTRI, Vanrafia, Kerendia, Titan, JYNARQUE.
Industry payments across PA — which companies pay providers there.
